Concord Biotech Limited (NSE: CONCORDBIO)
India
· Delayed Price · Currency is INR
2,151.05
+15.15 (0.71%)
Dec 24, 2024, 3:30 PM IST
Concord Biotech Revenue
Concord Biotech had revenue of 3.10B INR in the quarter ending September 30, 2024, with 18.23% growth. This brings the company's revenue in the last twelve months to 10.86B, up 11.88% year-over-year. In the fiscal year ending March 31, 2024, Concord Biotech had annual revenue of 10.17B with 19.20% growth.
Revenue (ttm)
10.86B
Revenue Growth
+11.88%
P/S Ratio
20.72
Revenue / Employee
7.88M
Employees
1,377
Market Cap
225.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 10.17B | 1.64B | 19.20% |
Mar 31, 2023 | 8.53B | 1.40B | 19.67% |
Mar 31, 2022 | 7.13B | 959.91M | 15.56% |
Mar 31, 2021 | 6.17B | 1.05B | 20.42% |
Mar 31, 2020 | 5.12B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition